The import of Opacifying Preparations, X-Ray, and Diagnostic Reagents to Singapore has experienced fluctuations over the past decade. Starting from a high point in 2013 with $6.26 million, the value saw a significant decline until 2015 before gradually recovering. The year-on-year variations have shown significant peaks, such as in 2018 with a 52.96% increase, indicating volatility in demand or supply chains. In 2023, the imports stood at $7.5134 million, reflecting a modest year-on-year increase of 2.21% from 2022. The 5-year CAGR up to 2023 was nearly flat at -0.2%. The forecast anticipates a steady growth with an average annual increase of 1.49% over the next five years, reaching $8.2935 million by 2028, marking an overall growth rate of 7.67%.
Future trends to watch for include:
- Technological advancements in diagnostic reagents that could drive demand
- Changes in healthcare policies and investment in Singapore
- Global supply chain disruptions or improvements
- Advances in alternative diagnostic methods that might affect reagent usage
